Table 4.
Multimorbidity clusters in a population of hospitalised patients with COVID-19.
| Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | |
|---|---|---|---|---|---|---|
| Number of patients, n (%) | 1225 (20.3) | 648 (10.7) | 902 (14.9) | 2293 (38.1) | 682 (11.3) | 286 (4.7) |
| Age, median (IQR) | 77 (67–85) | 75 (59–83) | 70 (59–79) | 63 (49–78) | 72 (61–82) | 82 (74–86) |
| Disease group | ||||||
| Autoimmune (%) | 2.1 | 1.2 | 1.7 | 1.8 | 2.0 | 1.0 |
| Metabolic & endocrine (%) | 0.0 | 19.3 | 12.7 | 9.6 | 100.0 | 8.0 |
| Respiratory (%) | 9.9 | 8.6 | 100.0 | 0.0 | 10.1 | 15.7 |
| Cardiovascular (%) | 100.0 | 0.0 | 15.0 | 0.0 | 69.1 | 100.0 |
| Mental & neurological (%) | 0.0 | 100.0 | 5.5 | 0.0 | 4.4 | 100.0 |
| Neoplasms (%) | 4.2 | 2.5 | 4.3 | 5.9 | 2.3 | 3.5 |
| Digestive (%) | 1.6 | 2.5 | 1.0 | 1.7 | 2.2 | 0.0 |
| Genitourinary (%) | 15.6 | 9.4 | 6.0 | 9.0 | 15.0 | 12.2 |
| Mortality (%) | 23.8 | 23.5 | 22.0 | 15.3 | 21.8 | 29.4 |
Values in bold correspond to three conditions with the highest prevalence within patient groups (clusters of conditions). Underlined values represent other, less common conditions that have a higher prevalence than in other groups.